Frontiers
US$ 21.14
glp-1 pediatric Use Increased Significantly Among Patients With T2D in Past 5 Years | ADA 2025 GLP-1 agonists in pediatric obesity:
Description
They found that T1D participants had repeated return visits to the ED in the following weeks, and DKA was frequently misdiagnosed
doi: 10.7150/thno.30787
What Medical Tests are Used to Diagnose Gastroparesis
Special considerations include pregnancy planning and perioperative management
Structured strength training, and 1.2 to 1.6 grams of protein per kilo of body weight per day
Abnormal results before starting GLP-1 therapy are not necessarily disqualifying they are informative
